Nutrition is the missing variable in obesity care Deficiencies appear before weight loss begins and persist across every treatment pathway People living with obesity frequently present with chronic micronutrient deficiencies driven by diet quality,…
GLP-1 therapies and bariatric surgery are transforming obesity care – but at a cost. Up to 40% of weight loss may come from muscle, not fat. With protein intake often…
GLP-1 receptor agonists are revolutionizing obesity and diabetes care – but new data from over 460,000 patients reveals a concerning trend: 1 in 5 users develop nutritional deficiencies within a…
With ≥15% weight loss from AOMs like semaglutide and tirzepatide, nutritional guidance is critical. Almandoz et al. (2024) provide practical recommendations on protein intake, micronutrient monitoring, and individualized care—helping clinicians…
GLP-1 and GIP/GLP-1 therapies reduce calorie intake—but Christensen et al. (2024) show we know little about diet quality, protein intake, or micronutrient risks. With use rising, tailored nutritional support is…
Even with high caloric intake, people with overweight or obesity often face silent micronutrient deficiencies—impacting metabolism, cognition, and long-term weight outcomes. This review by Astrup & Bügel (2017) underscores the…
